CYTOVATION

At Cytovation, we are on a mission to make immunotherapy effective across a wide range of cancer types... Cytovation's technology is broadly applicable across solid tumor types. Our goal is to bring CyPep-1 to as many patients as possible, initially focusing on areas of highest unmet need... Cytovation builds on over 15 years of cutting-edge research from two leading Norwegian institutions; University of Bergen and Haukeland University Hospital.

Also known as: Cytovation AS, Cytovation ASA

Registration numbers: 983644600 (W)

Primary location: Bergen Norway